Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50

Science

Volumn 285, Issue 5433, 1999, Pages 1576-1579

  Kleiman, Frida E ^a   Manley, James L ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; MESSENGER RNA; NUCLEAR PROTEIN; RNA POLYMERASE II;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DNA REPAIR; HELA CELL; IMMUNOPRECIPITATION; ONCOGENE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA PROCESSING; RNA TRANSCRIPTION;

ANTIBODIES, MONOCLONAL; CARRIER PROTEINS; CELL NUCLEUS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; POLY A; PROLIFERATING CELL NUCLEAR ANTIGEN; RAD51 RECOMBINASE; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; RNA POLYMERASE II; RNA PRECURSORS; RNA, MESSENGER; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; ZINC FINGERS;

EID: 0001221269     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5433.1576     Document Type: Article

References (49)

1. E. Wahle and W. Keller, Trends Biochem. Sci. 21, 247 (1996); D. F. Colgan and J. L. Manley, Genes Dev. 11, 2755 (1997).
2. E. Wahle and W. Keller, Trends Biochem. Sci. 21, 247 (1996); D. F. Colgan and J. L. Manley, Genes Dev. 11, 2755 (1997).
3. J. C. Dantonel, K. G. K. Murthy, J. L. Manley, L. Tora, Nature 389, 399 (1997).
4. S. McCracken et al., ibid. 385, 357 (1997).
5. Y. Hirose and J. L. Manley, ibid. 395, 93 (1998).
6. E. Whitelaw and N. Proudfoot, EMBO J. 5, 2915 (1986); J. Logan, E. Falck-Pedersen, J. E. Darnell, T. Shenk, Proc. Natl. Acad. Sci. U.S.A. 84, 8306 (1987);
7. E. Whitelaw and N. Proudfoot, EMBO J. 5, 2915 (1986); J. Logan, E. Falck-Pedersen, J. E. Darnell, T. Shenk, Proc. Natl. Acad. Sci. U.S.A. 84, 8306 (1987);
8. S. Connelly and J. L. Manley, Genes Dev. 2, 440 (1988).
9. D. F. Colgan, K. G. K. Murthy, C. Prives, J. L. Manley, Nature 384, 282 (1996); D. F. Colgan, K. G. K. Murthy, W. Zhao, C. Prives, J. L. Manley, EMBO J. 17, 1053 (1998).
10. D. F. Colgan, K. G. K. Murthy, C. Prives, J. L. Manley, Nature 384, 282 (1996); D. F. Colgan, K. G. K. Murthy, W. Zhao, C. Prives, J. L. Manley, EMBO J. 17, 1053 (1998).
11. Y. Takagaki, R. L. Seipelt, M. L. Peterson, J. L. Manley, Cell 87, 941 (1996); Y. Takagaki and J. L. Manley, Mol. Cell 2, 761 (1998).
12. Y. Takagaki, R. L. Seipelt, M. L. Peterson, J. L. Manley, Cell 87, 941 (1996); Y. Takagaki and J. L. Manley, Mol. Cell 2, 761 (1998).
13. Y. Takagaki, L. C. Ryner, J. L. Manley, Genes Dev. 3, 1711 (1989); G. M. Gilmartin and J. R. Nevins, Mol. Cell. Biol. 11, 2432 (1991); K. G. K. Murthy and J. L. Manley, J. Biol. Chem. 267, 14804 (1992).
14. Y. Takagaki, L. C. Ryner, J. L. Manley, Genes Dev. 3, 1711 (1989); G. M. Gilmartin and J. R. Nevins, Mol. Cell. Biol. 11, 2432 (1991); K. G. K. Murthy and J. L. Manley, J. Biol. Chem. 267, 14804 (1992).
15. Y. Takagaki, L. C. Ryner, J. L. Manley, Genes Dev. 3, 1711 (1989); G. M. Gilmartin and J. R. Nevins, Mol. Cell. Biol. 11, 2432 (1991); K. G. K. Murthy and J. L. Manley, J. Biol. Chem. 267, 14804 (1992).
16. Y. Takagaki, J. L. Manley, C. C. MacDonald, J. Wilusz, T. Shenk, Genes Dev. 4, 2112 (1990).
17. Y. Takagaki, C. C. MacDonald, T. Shenk, J. L. Manley, Proc. Natl. Acad. Sci. U.S.A. 89, 1403 (1992); C. C. MacDonald, J. Wilusz, T. Shenk, Mol. Cell. Biol. 14, 6647 (1994); K. Beyer, T. Dandekar, W. Keller J. Biol. Chem. 272, 26769 (1997); Y. Takagaki and J. L. Manley, Mol. Cell. Biol. 17, 3907 (1997).
18. Y. Takagaki, C. C. MacDonald, T. Shenk, J. L. Manley, Proc. Natl. Acad. Sci. U.S.A. 89, 1403 (1992); C. C. MacDonald, J. Wilusz, T. Shenk, Mol. Cell. Biol. 14, 6647 (1994); K. Beyer, T. Dandekar, W. Keller J. Biol. Chem. 272, 26769 (1997); Y. Takagaki and J. L. Manley, Mol. Cell. Biol. 17, 3907 (1997).
19. Y. Takagaki, C. C. MacDonald, T. Shenk, J. L. Manley, Proc. Natl. Acad. Sci. U.S.A. 89, 1403 (1992); C. C. MacDonald, J. Wilusz, T. Shenk, Mol. Cell. Biol. 14, 6647 (1994); K. Beyer, T. Dandekar, W. Keller J. Biol. Chem. 272, 26769 (1997); Y. Takagaki and J. L. Manley, Mol. Cell. Biol. 17, 3907 (1997).
20. Y. Takagaki, C. C. MacDonald, T. Shenk, J. L. Manley, Proc. Natl. Acad. Sci. U.S.A. 89, 1403 (1992); C. C. MacDonald, J. Wilusz, T. Shenk, Mol. Cell. Biol. 14, 6647 (1994); K. Beyer, T. Dandekar, W. Keller J. Biol. Chem. 272, 26769 (1997); Y. Takagaki and J. L. Manley, Mol. Cell. Biol. 17, 3907 (1997).
21. Y. Takagaki and J. L. Manley, Nature 372, 471 (1994).
22. K. G. K. Murthy and J. L. Manley, Genes Dev. 9, 2672 (1995).
23. Y. Takagaki and J. L. Manley, J. Biol. Chem. 267, 23471 (1992).
24. J. Gyuris, E. Golemis, H. Chertkov, R. Brent, Cell 75, 791 (1993).
25. Yeast interaction trap selection assays were performed as in (14). Bait plasmids were constructed by insertion of polymerase chain reaction amplified fragments into LexA(202+pl). A cDNA library from human fetal brain RNA was screened. Library plasmids from positive colonies were rescued, used to transform Escherichia coli, and sequenced. Specificity was confirmed with several other LexA fusion proteins. Although LexA-CstF-50 plus BARD1-B42 again resulted in reporter gene expression, no other combination tested resulted in detectable activity (22).
26. L. C. Wu et al., Nature Genet. 14, 430 (1996).
27. T. C. Ayi, J. T. Tsan, L. Y. Hwang, A. M. Bowcock, R. Baer, Oncogene 17, 2143 (1998); J. E. Meza, P. S. Brzovic, M. C. King, R. E. Klevit, Biol. Chem. 274, 5659 (1999).
28. T. C. Ayi, J. T. Tsan, L. Y. Hwang, A. M. Bowcock, R. Baer, Oncogene 17, 2143 (1998); J. E. Meza, P. S. Brzovic, M. C. King, R. E. Klevit, Biol. Chem. 274, 5659 (1999).
29. I. Irminger-Finger, J. V. Soriano, G. Vaudan, R. Montesano, A. P. Sappino J. Cell. Biol. 143, 1329 (1998).
30. T. H. Thai et al., Hum. Mol. Genet. 7, 195 (1998).
31. R. Scully et al., Cell 90, 425 (1997); Y. Jin et al., Proc. Natl. Acad. Sci. U.S.A. 94, 12075 (1997).
32. R. Scully et al., Cell 90, 425 (1997); Y. Jin et al., Proc. Natl. Acad. Sci. U.S.A. 94, 12075 (1997).
33. J. S. Humphrey et al., Proc. Natl. Acad. Sci. U.S.A. 94, 5820 (1997).
34. F. E. Kleiman and J. L. Manley, unpublished data.
35. 35S-labeled CstF-50. Conditions were as in the coimmunoprecipitation assays, except washing was with buffer B containing 300 mM NaCl.
36. 4 cut and fractionated by Superose-6 chromatography (25). Selected fractions were analyzed by immunoblotting with mAbs targeted against BARD1 (EE 6) (16), CstF-64 (9), or BRCA1 (MS110) (33). NE and fractions eluting from Superose-6 were immunoprecipitated with the anti-BARD1 polyclonal antibody, or the anti-CstF64 or BRCA1 mAbs, bound to protein A-Sepharose beads. Immunoprecipitations were carried out in buffer B at 4°C for 90 min, and washing was with buffer B. Aliquots of pellets and supematants were analyzed by SDS-PAGE and immunoblotting. The anti-BARD1 and CstF-64 antibodies did not cross-react with CstF-64 and BARD1, respectively, as judged by experiments with purified (BARD1-free) CstF and recombinant CST-BARD1 (22).
37. Y. Takagaki, L. C. Ryner, J. L. Manley, Cell 52, 731 (1988).
38. 2. NE and added proteins or antibodies were preincubated for 15 min at 30°C, after which the pre-mRNA was added and incubation continued for an additional 90 min. RNA products were isolated and fractionated on 5% polyacrylamide, 8.3 M urea gels.
39. R. Scully et al., Proc. Natl. Acad. Sci. U.S.A. 94, 5605 (1997).
40. R. Scully et al., Cell 88, 265 (1997).
41. A. Shinohara, H. Ogawa, T. Ogawa, Cell 69, 457 (1992); P. Baumann, F. E. Benson, S. C. West, ibid. 87, 757 (1996).
42. A. Shinohara, H. Ogawa, T. Ogawa, Cell 69, 457 (1992); P. Baumann, F. E. Benson, S. C. West, ibid. 87, 757 (1996).
43. E. Maldonado et al., Nature 381, 86 (1996).
44. L. C. Gowen et al., Science 281, 1009 (1998).
45. E. Warbrick, W. Heatherington, D. P. Lane, D. M. Glover, Nucleic Acids Res. 26, 3925 (1998).
46. R. Scully et al., Science 272, 123 (1996).
47. Y. Hirose and J. L. Manley, J. Biol. Chem. 272, 29636 (1997).
48. J. Chen, D. Livingston, R. Baer, personal communication.
49. Supported by National Institutes of Health (NIH) grant GM28983 to J.L.M. and an NIH Fogarty Fellowship to F.E.K. We thank Y. Takagaki for CstF plasmids and antibodies; R. Baer for BARD1 and BRCA1 encoding plasmids and anti-BARD1 antibodies; J. Chen and D. Livingston for the anti-BRCA1 antibody; R. Brent for yeast two-hybrid reagents; Y. Hirose for HeLa nuclear extract; and C. Prives, R. Baer, Y. Hirose, and R. Tacke for advice and discussions.